Circulating tumor cells (CTCs) are important markers for cancer diagnosis and monitoring.
However, CTCs detection remains challenging due to their scarcity, where most of the …

Epigenetic modulation of the immune response entails modifiable and inheritable
modifications that do not modify the DNA sequence. While there have been many studies on …

Despite improvements in cervical cancer diagnosis and treatment, the prognosis for cervical
cancer patients remains dismal due to the development of drug resistance, metastasis, and …

Abstract Aims Long non-coding RNAs (lncRNAs) are associated with cancer development,
while their relationship with the cancer-associated stromal components remains poorly …

Major fraction of the human genome is transcribed in to the RNA but is not translated in to
any specific functional protein. These transcribed but not translated RNA molecules are …

Distant metastases and drug resistance account for poor survival of patients with
gastrointestinal (GI) malignancies such as gastric cancer, pancreatic cancer, and colorectal …

Fluorouracil (5-FU) resistance has always been a formidable obstacle in the adjuvant
treatment of advanced colorectal cancer (CRC). In recent years, long non-coding RNAs …

Bladder cancer, a prevalent malignant neoplasm of the urinary tract, exhibits escalating
morbidity and mortality rates. Current diagnosis standards rely on invasive and costly …

In a precision medicine perspective, among the biomarkers potentially useful for early
diagnosis of cancers, as well as to define their prognosis and eventually to identify novel …

Background/Aim: Long non-coding RNAs (lncRNAs) are emerging as significant regulators
of gene expression and a novel promising biomarker for cancer diagnosis and prognosis …